Bollino, Jp M.
HRN: 26-63-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2025
CEFTRIAXONE 1G (VIAL)
02/06/2025
02/26/2025
IV DRIP
1.5g
Q12h
Febrile Infection Related Epilepsy
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes